Bio-Techne
TECH
571 hedge funds and large institutions have $11.2B invested in Bio-Techne in 2024 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 213 increasing their positions, 209 reducing their positions, and 45 closing their positions.
336% more call options, than puts
Call options by funds: $23.6M | Put options by funds: $5.42M
49% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 45
3% more funds holding
Funds holding: 556 → 571 (+15)
2% more repeat investments, than reductions
Existing positions increased: 213 | Existing positions reduced: 209
0% more capital invested
Capital invested by funds: $11.2B → $11.2B (+$5.87M)
1.98% less ownership
Funds ownership: 100.92% → 98.94% (-2%)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
Top Sellers
TECH Hedge Fund Activity: Q2 2024 in Review
571 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2024, worth a combined $11.2B — up 0.05% from $11.2B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new TECH positions and 45 closed out — a net gain of 22 holders — while 213 added to existing stakes and 209 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $205M. The largest seller was BlackRock, cutting an estimated $203M.
- 571 institutional investors held Bio-Techne (TECH) as of Q2 2024, up from 556 in Q1 2024.
- Funds reported $11.2B of Bio-Techne stock for Q2 2024, up 0.05% quarter-over-quarter.
- 67 funds opened new Bio-Techne positions in Q2 2024 and 45 closed out, a net change of +22 holders.
- The largest Bio-Techne buyer in Q2 2024 was T. Rowe Price Associates, an estimated $205M added.
- The largest Bio-Techne seller in Q2 2024 was BlackRock, an estimated $203M sold.
Based on aggregated 13F filings for Q2 2024.